title: [Pseudomonas and acute external otitis. Results of a microbiological study in patients without previous antibiotic treatment].
abstract: We report the results of a microbiological clinic study that was performed by our ENT Department between years 2000 and 2001 whose main objective was to determine, in Badajoz Area of Health, which bacteria were involved in the acute diffuse external otitis of patients without previous antibiotic treatment (two weeks before obtaining the samples). Of 79 isolated microorganisms in 62 patients that fulfilled the requirements established Pseudomonas, mainly P. Aeruginosa, represented a 46.83% altogether followed by Staphylococcus (18.98%). In almost one fourth part of the cases strains of associated fungi were identified.
authors.affiliation: Complejo Hospitalario Infanta Cristina, Badajoz. vicentepinorivero@terra.com
authors.forename: V
authors.initials: V
authors.lastname: Pino Rivero
authors.forename: C G
authors.initials: CG
authors.lastname: Pantoja Hernández
authors.forename: G
authors.initials: G
authors.lastname: González Palomino
authors.forename: M E
authors.initials: ME
authors.lastname: Mora Santos
authors.forename: G
authors.initials: G
authors.lastname: Pardo Romero
authors.forename: A
authors.initials: A
authors.lastname: Blasco Huelva
mesh_terms: D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D003627:Data Interpretation, Statistical; D005260:Female; D005658:Fungi / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D009428:Netilmicin / Q000008:administration & dosage / Q000627:therapeutic use; D010032:Otitis Externa / Q000188:drug therapy / Q000382:microbiology*; D015995:Prevalence; D011552:Pseudomonas Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012737:Sex Factors; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D009428:Netilmicin; D002939:Ciprofloxacin